Aerie pharmaceuticals announces appointment of carolyn mcauliffe, senior director, communications

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq:aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases today announced the appointment of carolyn mcauliffe, senior director, communications, reporting to tad heitmann, aerie's vice president of marketing. ms. mcauliffe will be responsible for the develo
AERI Ratings Summary
AERI Quant Ranking